RIGL
Rigel Pharmaceuticals Inc
NASDAQ: RIGL · HEALTHCARE · BIOTECHNOLOGY
$50.74
+0.38% today
Updated 2026-10-28
Market cap
$932.31M
P/E ratio
2.85
P/S ratio
3.34x
EPS (TTM)
$17.51
Dividend yield
—
52W range
$25 – $52
Volume
0.2M
Rigel Pharmaceuticals Inc (RIGL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$50.74
12-Month target
$32.39
2030 Target
$54.79
Intrinsic (DCF)
$248.87
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.2B | $0.3B | $0.4B | $0.4B | $0.5B | $0.6B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 2.85x (capped 25x) · Margin: 116.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.